BiBo Pharma is a contract development and manufacturing organization (CDMO) company for biologics. Headquartered in China (Shanghai) Pilot Free Trade Zone, BiBo Pharma is currently operating 50L/200L/500L/2000L stainless steel microbial fermentation GMP line, 200L/500L/2000L SUB mammalian cell culture GMP line, and corresponding liquid vial, PFS (pre-filled syringe) and lyophilization F&F line, which can provide service from DNA sequence to commercialization stage.

BiBo's over 49,000 square meters P03 large-scale commercial production site in Shanghai Lingang officially started pilling in early 2022 and will enter GMP operations in mid-2023, including single tank 30,000-liter stainless steel mammalian cell culture production line, single tank 30,000-liter stainless steel microbial fermentation production line, a gene therapy production line, and an independent F&F center and analytical testing center.